British Scientists Find New Treatment for Brittle Bone Disease

A new method to treat brittle bone disease in children was developed by British scientists.

The new treatment for Osteogenesis Imperfecta has been developed by scientists from the University of Sheffield and Sheffield Children's Hospital.

Gene Responsible for Recessive Form of Brittle Bone Disease Discovered
Researchers at the National Institutes of Health and other institutions have found the gene for unexplained forms of osteogenesis imperfecta (OI).

The findings were published in The Lancet.

This is the first study to clearly demonstrate that the use of the medicine risedronate can not only reduce the risk of fracture in children with brittle bones but also have rapid action, as the curves under fracture risk begin to diverge after only six weeks of treatment, reported Science Daily.

"We wanted to show that the use of risedronate could significantly impact children's lives by reducing fracture rates - and it did," said Nick Bishop, professor of paediatric bone disease at the University of Sheffield.

Use parathyroid hormone to fight brittle bone disease
A study conducted on more than 1600 women reveals that parathyroid hormone (parathormone) increases the patient’s bone density and cut the risk

"The fact that this medicine can be given by mouth at home (other similar medicines are given by a drip in hospital) makes it family-friendly," he said.

Source-IANS

How Bone's Material Flaws Lead To Brittle Bone Disease
Massachusetts Institute of Technology (MIT) researchers have for the first time carried out a multi-scale analysis to shed light on how bone's material flaws lead to brittle bone disease.

Scientists Discover New Ways To Treat Brittle Bone Disease
Scientists have discovered new ways to help detect and treat the debilitating brittle bone disease.